Migration (32)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kotyark Industries Limited confirms lock-in details of its equity shares as part of its migration from NSE Limited (EMERGE) platform to the … | |||||||||||||||
Kotyark Industries Limited confirms lock-in details of its equity shares as part of its migration from NSE Limited (EMERGE) platform to the Main Board of BSE. All 10,279,116 equity shares are free from lock-in and held in dematerialised form.
| |||||||||||||||
Kotyark Industries Limited confirms lock-in details of its equity shares as part of its migration from NSE Emerge platform to BSE Main … | |||||||||||||||
Kotyark Industries Limited confirms lock-in details of its equity shares as part of its migration from NSE Emerge platform to BSE Main Board. A total of 10,279,116 fully paid-up equity shares are free from lock-in and held in dematerialised form.
| |||||||||||||||
Kotyark Industries Limited confirms lock-in details of equity shares as part of its migration from NSE Emerge platform to BSE Mainboard. All … | |||||||||||||||
Kotyark Industries Limited confirms lock-in details of equity shares as part of its migration from NSE Emerge platform to BSE Mainboard. All 10,279,116 shares are free from lock-in and held in dematerialised form.
| |||||||||||||||
NSE announces migration of Kotyark Industries Limited equity shares from SME EMERGE platform to the Capital Market Segment (Main Board), … | |||||||||||||||
NSE announces migration of Kotyark Industries Limited equity shares from SME EMERGE platform to the Capital Market Segment (Main Board), effective March 12, 2026.
| |||||||||||||||
Vital Chemtech Limited's equity shares will migrate from NSE SME Emerge platform to the Capital Market Segment (Main Board) effective March … | |||||||||||||||
Vital Chemtech Limited's equity shares will migrate from NSE SME Emerge platform to the Capital Market Segment (Main Board) effective March 11, 2026. The stock will trade under symbol VITAL with ISIN INE0L4K01016.
| |||||||||||||||
SEBI issues settlement order for VCF settlement applications under the Venture Capital Funds Settlement Scheme 2025, addressing … | |||||||||||||||
SEBI issues settlement order for VCF settlement applications under the Venture Capital Funds Settlement Scheme 2025, addressing non-compliant VCF schemes whose liquidation periods had expired.
| |||||||||||||||
Insolation Energy Limited (BSE: 543620) announces board approval for unaudited financial results for H1 FY2026 and allotment of 51,625 … | |||||||||||||||
Insolation Energy Limited (BSE: 543620) announces board approval for unaudited financial results for H1 FY2026 and allotment of 51,625 equity shares under ESOP 2024, in connection with its migration from BSE SME to BSE Mainboard.
| |||||||||||||||
Insolation Energy Limited (Symbol: INA) will migrate from the SME Platform of BSE to the Capital Market Segment (Main Board) of NSE with … | |||||||||||||||
Insolation Energy Limited (Symbol: INA) will migrate from the SME Platform of BSE to the Capital Market Segment (Main Board) of NSE with effect from March 09, 2026. Trading will be in the Normal Market segment under Rolling Settlement in compulsory demat.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, prepared as part of the company's migration from BSE SME to Mainboard platform.
| |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for half year ended September 30, 2025, in connection with migration from SME to Mainboard platform.
| |||||||||||||||